Christopher Bryant
6Patents
2h-index
16Co-inventors
48Inventor score
Filing activity: Oct 29, 1993 → Mar 2, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8198407B1 | Sequential protein isolation and purification schemes by affinity chromatography | Chemistry; Metallurgy | 22 | Active |
| US5464747A | Oxidation-resistant muteins of .beta.-galactosidase fragments | Emerging Cross-Sectional Technologies | 10 | Expired |
| US11844764B2 | Agitation process for preparing a carbetocin drug product | Human Necessities | 0 | Active |
| US11298399B2 | Carbetocin drug product and process for preparing same | Human Necessities | 0 | Active |
| US10967040B2 | Methods of treating prader-willi syndrome with carbetocin | Human Necessities | 0 | Active |
| US11207373B2 | Agitation process for preparing a carbetocin drug product | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.